U.S. FDA Approves Expanded Label for Astellas’ IZERVAY for Geographic Atrophy
Astellas Pharma, announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAY for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration...